O

Oncolytics Biotech
D

ONCY

0.84000
USD
-0.01
(-0.60%)
مفتوح الان
حجم التداول
3,460
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
64,742,235
أصول ذات صلة
    B
    BLU
    -0.02500
    (-0.33%)
    7.49000 USD
    C
    CRVS
    -0.41000
    (-8.18%)
    4.60000 USD
    I
    IMGN
    0
    (0%)
    0.000000 USD
    M
    MGNX
    -0.04000
    (-1.25%)
    3.15000 USD
    O
    ONTX
    0
    (0%)
    0.000000 USD
    P
    PKI
    1.920
    (1.57%)
    124.190 USD
    المزيد
الأخبار

العنوان: Oncolytics Biotech

القطاع: Healthcare
الصناعة: Biotechnology
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.